The international CAR T-cell therapy market is experiencing substantial growth, driven by increasing demand for advanced cancer treatment options. This exponential expansion is fueled by factors such as the approval of CAR T-cell therapies for various treatments, advancements in production technologies, and growing research and development efforts.